301
Views
14
CrossRef citations to date
0
Altmetric
Original Articles

Development and Validation of an HPLC Method for the Impurity and Quantitative Analysis of Etoricoxib

, , , , &
Pages 2551-2566 | Received 01 Apr 2003, Accepted 29 Apr 2003, Published online: 06 Feb 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Janvi Shah & Rajendra Kotadiya. (2022) A Critical Review on Analytical Methods for Recently Approved FDC Drugs: Pregabalin and Etoricoxib. Critical Reviews in Analytical Chemistry 52:5, pages 1048-1068.
Read now
Theresa K. Natishan. (2004) Recent Developments of Achiral HPLC Methods in Pharmaceuticals Using Various Detection Modes. Journal of Liquid Chromatography & Related Technologies 27:7-9, pages 1237-1316.
Read now
Xiaoyi Gong, Yi Shen & Bing Mao. (2004) Quantitation of Ammonium Cations in Pharmaceutical Samples by Nonaqueous Capillary Electrophoresis with Indirect UV Detection. Journal of Liquid Chromatography & Related Technologies 27:4, pages 661-675.
Read now

Articles from other publishers (11)

A. Kh. Amandusova, A. E. Kovalenko, A. V. Morozov, K. R. Savelyeva, T. L. Batalova, O. A. Ostapyuk, L. V. Persanova, T. Yu. Andreevicheva, A. G. Beniashvili, V. N. Shestakov & S. V. Polyakov. (2023) Development and Validation of a Method for the Quantitative Determination of Etoricoxib in Liquid Dosage Form. Drug development & registration 12:2, pages 95-102.
Crossref
Sarju Adhikari, Jingzhi Tian & Abu M. Rustum. (2023) Comprehensive study on degradation profile of firocoxib and structural elucidation of its key degradation products. Journal of Pharmaceutical and Biomedical Analysis 224, pages 115192.
Crossref
Muhammad Alzweiri, Mariam Sallam, Walid Al-Zyoud & Khaled Aiedeh. (2018) Stability Study of Etoricoxib a Selective Cyclooxygenase-2 Inhibitor by a New Single and Rapid Reversed Phase HPLC Method. Symmetry 10:7, pages 288.
Crossref
Maciej Stawny, Mikołaj Piekarski & Barbara Marciniec. 2016. Handbook of Trace Analysis. Handbook of Trace Analysis 181 202 .
György Székely, Bruno Henriques, Marco Gil & Carlos Alvarez. (2014) Experimental design for the optimization and robustness testing of a liquid chromatography tandem mass spectrometry method for the trace analysis of the potentially genotoxic 1,3-diisopropylurea. Drug Testing and Analysis 6:9, pages 898-908.
Crossref
Małgorzata Starek & Monika Dąbrowska. (2012) Chromatographic techniques in analysis of cyclooxygenase-2 inhibitors in drugs and biological samples. Open Chemistry 10:3, pages 711-730.
Crossref
Małgorzata Starek. (2011) Review of the applications of different analytical techniques for coxibs research. Talanta 85:1, pages 8-27.
Crossref
Adrian Hall, Andy Billinton, Susan H. Brown, Anita Chowdhury, Nicholas M. Clayton, Gerard M.P. Giblin, Mairi Gibson, Paul A. Goldsmith, David N. Hurst, Alan Naylor, Caroline F. Peet, Tiziana Scoccitti, Alexander W. Wilson & Wendy Winchester. (2009) Discovery of sodium 6-[(5-chloro-2-{[(4-chloro-2-fluorophenyl)methyl]oxy}phenyl)methyl]-2-pyridinecarboxylate (GSK269984A) an EP1 receptor antagonist for the treatment of inflammatory pain. Bioorganic & Medicinal Chemistry Letters 19:9, pages 2599-2603.
Crossref
Sérgio Luiz Dalmora, Maximiliano da Silva Sangoi, Lucélia Magalhães da Silva, Rui Oliveira Macedo & Thiago Barth. (2008) Validation of a capillary zone electrophoresis method for the comparative determination of etoricoxib in pharmaceutical formulations. Journal of Separation Science 31:1, pages 169-176.
Crossref
George X. Zhou, Louis Crocker, Jing Xu, Jose Tabora & Zhihong Ge. (2006) In-line Measurement of a Drug Substance via Near Infrared Spectroscopy to Ensure a Robust Crystallization Process. Journal of Pharmaceutical Sciences 95:11, pages 2337-2347.
Crossref
R. Nageswara Rao, S. Meena & A. Raghuram Rao. (2005) An overview of the recent developments in analytical methodologies for determination of COX-2 inhibitors in bulk drugs, pharmaceuticals and biological matrices. Journal of Pharmaceutical and Biomedical Analysis 39:3-4, pages 349-363.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.